China succeeded in its second attempt to establish a dispute panel at the World Trade Organization to review whether subsidies from the Inflation Reduction Act unlawfully favor US goods over imports.
“If they end up with a larger-than-normal number of high-risk patients, they will get additional subsidization from the government for the costs,” James Capretta, senior fellow at the right ...